COVID-19: Nanomix Wins BARDA Funding For Mobile Point-Of-Care Assay
The US government’s Biomedical Advanced Research and Development Authority has awarded Nanomix up to $570,000 to develop a SARS-CoV-2 test for its portable, rapid Nanomix eLab analyzer.
You may also be interested in...
The US government is helping Sonica develop ADAM, a patch monitor that tracks the user's breathing patterns and other physiologic signals to detect SARS-CoV-2 infections.
Abbott has launched its first COVID-19 antibody test to help determine if a person has been previously infected with the virus. The diagnostics giant said it intends to ship a total of 4 million tests in April.
BD and BioMedomics will soon begin distributing a new rapid point-of-care test that can detect antibodies in blood to confirm current or past exposure to COVID-19.